Monepantel

PharmAust share price soars on release of results

Finfeed Archived Jun 18, 2020

PharmAust (ASX: PAA) received positive news regarding the performance of its treatments in reducing SARS-CoV-2 (COVID-19)

PharmAust shares soar following promising COVID-19 treatment results

Finfeed Archived Jun 04, 2020

PharmAust's (ASX:PAA) demonstrates both infectivity and replication of SARS-CoV-2 virus particles can be suppressed in cell cultures.

PharmAust's phase II monepantel trials a success

Finfeed Archived May 12, 2020

PharmAust (ASX: PAA) has released promising data in relation to its monepantel canine trial, investigating the anti-cancer effects of monepantel tablets in dogs.